| A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing M Prapa, S Caldrer, C Spano, M Bestagno, G Golinelli, G Grisendi, ... Oncotarget 6 (28), 24884, 2015 | 102 | 2015 |
| Role of neurotrophins on dermal fibroblast survival and differentiation E Palazzo, A Marconi, F Truzzi, K Dallaglio, T Petrachi, P Humbert, ... Journal of cellular physiology 227 (3), 1017-1025, 2012 | 82 | 2012 |
| A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology O Candini, G Grisendi, EM Foppiani, M Brogli, B Aramini, V Masciale, ... Scientific reports 9 (1), 7154, 2019 | 76 | 2019 |
| Soluble TRAIL armed human MSC as gene therapy for pancreatic cancer C Spano, G Grisendi, G Golinelli, F Rossignoli, M Prapa, M Bestagno, ... Scientific reports 9 (1), 1788, 2019 | 70 | 2019 |
| Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas G Grisendi, C Spano, N D'souza, V Rasini, E Veronesi, M Prapa, ... Stem Cells 33 (3), 859-869, 2015 | 66 | 2015 |
| E‐FABP induces differentiation in normal human keratinocytes and modulates the differentiation process in psoriatic keratinocytes in vitro K Dallaglio, A Marconi, F Truzzi, R Lotti, E Palazzo, T Petrachi, A Saltari, ... Experimental dermatology 22 (4), 255-261, 2013 | 62 | 2013 |
| GD2 CAR T cells against human glioblastoma M Prapa, C Chiavelli, G Golinelli, G Grisendi, M Bestagno, R Di Tinco, ... NPJ precision oncology 5 (1), 93, 2021 | 59 | 2021 |
| MSC-delivered soluble TRAIL and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma F Rossignoli, C Spano, G Grisendi, EM Foppiani, G Golinelli, I Mastrolia, ... Theranostics 9 (2), 436, 2019 | 56 | 2019 |
| GD2 expression in breast cancer G Orsi, M Barbolini, G Ficarra, G Tazzioli, P Manni, T Petrachi, I Mastrolia, ... Oncotarget 8 (19), 31592, 2017 | 50 | 2017 |
| Soluble fas ligand is essential for blister formation in pemphigus R Lotti, E Shu, T Petrachi, A Marconi, E Palazzo, M Quadri, A Lin, ... Frontiers in Immunology 9, 370, 2018 | 43 | 2018 |
| Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma T Petrachi, A Romagnani, A Albini, C Longo, G Argenziano, G Grisendi, ... Oncotarget 8 (4), 6914, 2017 | 38 | 2017 |
| Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion K Dallaglio, T Petrachi, A Marconi, F Truzzi, R Lotti, A Saltari, P Morandi, ... British journal of cancer 110 (1), 199-207, 2014 | 37 | 2014 |
| CD271 mediates stem cells to early progeny transition in human epidermis F Truzzi, A Saltari, E Palazzo, R Lotti, T Petrachi, K Dallaglio, C Gemelli, ... Journal of Investigative Dermatology 135 (3), 786-795, 2015 | 35 | 2015 |
| An alternative approach to investigate biofilm in medical devices: A feasibility study T Petrachi, E Resca, MS Piccinno, F Biagi, V Strusi, M Dominici, ... International journal of environmental research and public health 14 (12), 1587, 2017 | 33 | 2017 |
| Human Mesenchymal Stem Cell Combined with a New Strontium-Enriched Bioactive Glass: An ex-vivo Model for Bone Regeneration D Bellucci, E Veronesi, V Strusi, T Petrachi, A Murgia, I Mastrolia, ... Materials 12 (21), 3633, 2019 | 30 | 2019 |
| Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo R Lotti, E Palazzo, T Petrachi, K Dallaglio, A Saltari, F Truzzi, M Quadri, ... International Journal of Molecular Sciences 17 (1), 89, 2016 | 16 | 2016 |
| Isolation and characterization of squamous cell carcinoma-derived stem-like cells: role in tumor formation K Dallaglio, T Petrachi, A Marconi, F Truzzi, R Lotti, A Saltari, P Morandi, ... International Journal of Molecular Sciences 14 (10), 19540-19555, 2013 | 12 | 2013 |
| mTOR pathway expression as potential predictive biomarker in patients with advanced neuroendocrine tumors treated with everolimus F Gelsomino, A Casadei-Gardini, F Caputo, G Rossi, F Bertolini, ... Cancers 12 (5), 1201, 2020 | 11 | 2020 |
| Author Correction: A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (Scientific Reports,(2019), 9, 1,(7154), 10 … O Candini, G Grisendi, EM Foppiani, M Brogli, B Aramini, V Masciale, ... Scientific Reports 10 (1), N/A-N/A, 2020 | 9 | 2020 |
| Proteomic Analysis of PTCH1+/− Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma … G Ponti, G Bertazzoni, L Pastorino, E Monari, A Cuoghi, S Bergamini, ... BioMed Research International 2013 (1), 794028, 2013 | 8 | 2013 |
